Please login to the form below
Catalent
This page shows the latest Catalent news and features for those working in and with pharma, biotech and healthcare.
Moderna seeks full FDA approval for its COVID-19 vaccine
In the US, the company is collaborating with Lonza Portsmouth for drug substance production and further partnerships with Catalent, Baxter BioPharma Solutions, Sanofi and Thermo Fisher Scientific for fill/finish services.
Latest news
-
EU concludes discussions with Moderna for COVID-19 vaccine
In parallel, we are scaling up our manufacturing capability with our strategic partners, Lonza, Catalent and Rovi, to address this global health emergency with a safe and effective vaccine,” said Stéphane
-
US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
In parallel, we are scaling up our manufacturing capability with our strategic partners, Lonza, Catalent and Rovi, to address this global health emergency with a safe and effective vaccine,” he added.
-
Amicus forms gene therapy manufacturing partnership with Catalent
Biotech invests to speed gene therapies into clinical trials. US biotech Amicus Therapeutics is to work with drug development services company Catalent Biologics to develop its cell and gene therapy manufacturing ... Amicus will work with Paragon Gene
-
Catalent preps for complex therapy boom with $1.2bn Paragon buy
viruses and CAR-T cell therapies, which Catalent says is “one of the fastest-growing areas of healthcare.”. ... Paragon brings to Catalent a complementary capability that will fundamentally enhance our biologics business and our end-to-end integrated
-
KaloBios files for bankruptcy protection
Miami and a number of contractors including Lonza, Catalent, INC Research and PPD.
More from news
Approximately 2 fully matching, plus 6 partially matching documents found.
Latest Intelligence
-
Deal Watch May 2016
to deficiencies at the plant operated by Catalent [its CMO].
-
Deal Watch January 2016
Last up, with a headline value of $619m, is Roche's option deal with Catalent/Redwood. ... 750. Catalent| Redwood Bioscience/ Roche. Research collaboration. Non-exclusive access to Redwood's SMARTag platform with an option to commercial licences to
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
Philip Payne completes Concept Life Sciences’ leadership team
Prior to this, he was business development director Europe and Asia for Sterile Technologies at Catalent Pharma Solutions.
-
Former Boehringer Ingelheim US CEO joins Inotek
He currently serves as a member of the board of directors at Catalent, Mallinckrodt Pharmaceuticals and TherapeuticsMD.
-
Patrick Fabbio named CFO at electroCore
Prior to NPS, Fabbio served in a range of senior financial positions including VP finance at Catalent Pharma Solutions, CFO at Ikano Therapeutics and senior corporate finance, commercial and transactional roles
-
Catalent promotes Sharon Johnson within new organisation
Catalent Pharma Solutions has appointed Sharon Johnson as senior VP of global quality and regulatory of its new quality, product development and regulatory affairs organisation. ... Prior to joining Catalent, Johnson served as VP of quality for GE
-
Catalent appoints two board members
Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their experience to advise Catalent, a leading player in providing drug development, ... We welcome both Jack and Rolf to our Board,”
More from appointments
Approximately 2 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Catalent
Telephone:1 888 765 8846. Address:. Catalent Pharma Solutions. 14 Schoolhouse Road Somerset.
-
Catalent Pharma Solutions
Catalent Pharma Solutions.
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Planting the Seeds for Future Women Leaders in Medicine
- FDA approves SpringWork’s Ogsiveo as first therapy for desmoid tumours
- GSK shares positive phase 3 results for Blenrep combination in multiple myeloma
- Stem cell therapy trial shows promising results for treating progressive MS
- Cancer Research UK calls on government to create ten-year cancer plan
- Risk calculator to prevent heart attacks and strokes in type 2 diabetes patients
No results were found
PMHub
Anthem PR
With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
